None listed
Conditions
Interventions
Test Group:Take one capsule daily with or without food for 60 consecutive days
Sponsors
Central Hospital of Fengxian District, Shanghai
Eligibility
Sex/Gender
All
Age
35 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Age between 35-60 years, with equal number of males and females (20 subjects aged 35-45 and 20 subjects aged 45-60); (2) Able to read Chinese and accurately understand the trial process, voluntarily participated in the trial and signed the informed consent form for the research; (3) Able to cooperate with and attend follow-up visits as required, promptly report personal health status or any changes in medication, adverse reaction symptoms, and able to comply with research requirements and schedule arrangements.
Exclusion criteria
Exclusion criteria: (1) Patients with severe diseases of the heart, liver, kidney, hematopoietic system, etc.; (2) Patients with severe mental illness or cognitive impairment who cannot make independent decisions; (3) Possible vascular, traumatic, or medically-induced decline in motor function; (4) Consumption of products related to the subject's function (such as ergothioneine, hyaluronic acid, spermidine, sialic acid, bird's nest, etc.) within the past 2 weeks; (5) Use of any antibiotics or alcohol abuse in the past 1 month; (6) Patients who have participated in other drug clinical trials in the past 1 month; (7) Pregnant, planning to become pregnant, or lactating women; (8) Patients who may be allergic to the test samples or their ingredients; (9) Individuals assessed by the investigator as unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial image acquisition and analysis (VISIA CR5): Image acquisition analyzes the area and number of crow's feet wrinkles;Skin Color ITA° Value (VISIA CR5);Percentage of facial pigmented spots (VISIA CR5): Facial Pigmented Spots;Skin Elasticity (Cutometer dual MPA580);Skin Stratum Corneum Moisture Content Value (Corneometer CM825);Observation Index Scoring of Scalp Hair Microenvironment and Hair Quality: Itching, Oiliness, Dandruff Severity, and Hair Loss Situation;Dermatoscopy (MoleMaxHD): Analysis of total hair count, hair density;Blood pressure levels;Body composition analysis (height, weight, muscle mass, skeletal muscle, body fat percentage, waist circumference (Waist cir.), visceral fat area (VFA), basal metabolic rate (BMR));Fatigue Scale-14 Score (FS-14);Brain Test: Instant Memory, Concentration, and Reaction Test (completed using the Wind-style Brain Training mini-program);Objective sleep assessment: Using the Huawei Band 9 to assess subjects' sleep: sleep onset time, wake-up time, number of awakenings, awake duration, deep sleep, light sleep, rapid eye movement (REM), total sleep time;Pittsburgh Sleep Quality Index (PSQI) score;DNA Methylation Age Test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mental status, sleep, diet, urination and defecation are the main clinical symptoms.;Blood routine, urine routine, liver and kidney function, blood pregnancy test; | — |
Countries
China
Contacts
Public ContactZhu Haiying
Central Hospital of Fengxian District, Shanghai
Outcome results
None listed